Klinger Shannon Thyme bought MRNA
February 11, 2026 · Form 4 insider transaction
Klinger Shannon Thyme bought 2,630 shares of Moderna, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,630
Price
$0.00
Total value
N/A
InsiderKlinger Shannon Thyme
Role—
CompanyModerna, Inc. (MRNA)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after55,861
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on February 28, 2023 (the "2023 PSUs").